Skip to main navigation Skip to search Skip to main content

IgA Vasculitis following AstraZeneca/Oxford COVID-19, case report

  • Nasser Alzoabi
  • , Jamal Alqahtani
  • , Bader Algamdi
  • , Nada Alghamdi*
  • , Ayesha Ahmed
  • , Gaeda Alkaltham
  • , Tala Beidas
  • , Omar M. Alakloby
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Immunoglobulin A (IgA) vasculitis, also known as Henoch–Schönlein purpura, is an immune-mediated vasculitis that affects small vessels. IgA vasculitis could be triggered by numerous conditions including infectious and non-infectious conditions. So far, few reported cases of Covid-19 vaccines related vasculitis. We report a case of IgA vasculitis after AstraZeneca/Oxford COVID-19 vaccine. A 29-year-old healthy man who developed purpuric skin lesions one week after his second AstraZeneca/Oxford COVID-19 vaccine which complicated by glomerulonephritis and gastrointestinal involvement. Skin biopsy revealed fi-brinoid necrosis and leukocytoclasia consistent with small vessel vasculitis. Due to the temporal association, AstraZeneca/Oxford COVID-19 vaccine-related IgA vasculitis would be the most likely explanation. (www.actabiomedica.it).

Original languageEnglish
Article numbere2023074
JournalActa Biomedica
Volume94
Issue number6
DOIs
StatePublished - 5 Dec 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AstraZeneca/Oxford COVID-19 vaccine
  • IgA vasculitis
  • skin biopsy

Fingerprint

Dive into the research topics of 'IgA Vasculitis following AstraZeneca/Oxford COVID-19, case report'. Together they form a unique fingerprint.

Cite this